nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—Dehydration—Metformin—polycystic ovary syndrome	0.0389	0.0394	CcSEcCtD
Dolasetron—Abdominal distension—Metformin—polycystic ovary syndrome	0.0364	0.0368	CcSEcCtD
Dolasetron—Pancreatitis—Metformin—polycystic ovary syndrome	0.0354	0.0359	CcSEcCtD
Dolasetron—Sweating increased—Metformin—polycystic ovary syndrome	0.0352	0.0357	CcSEcCtD
Dolasetron—Drowsiness—Metformin—polycystic ovary syndrome	0.0322	0.0326	CcSEcCtD
Dolasetron—Bradycardia—Metformin—polycystic ovary syndrome	0.0295	0.0298	CcSEcCtD
Dolasetron—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0285	0.0289	CcSEcCtD
Dolasetron—Flushing—Metformin—polycystic ovary syndrome	0.0269	0.0272	CcSEcCtD
Dolasetron—Chills—Metformin—polycystic ovary syndrome	0.026	0.0263	CcSEcCtD
Dolasetron—Flatulence—Metformin—polycystic ovary syndrome	0.0248	0.0251	CcSEcCtD
Dolasetron—Dysgeusia—Metformin—polycystic ovary syndrome	0.0247	0.025	CcSEcCtD
Dolasetron—Tremor—Metformin—polycystic ovary syndrome	0.0236	0.0239	CcSEcCtD
Dolasetron—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0234	0.0237	CcSEcCtD
Dolasetron—Malaise—Metformin—polycystic ovary syndrome	0.0227	0.023	CcSEcCtD
Dolasetron—Syncope—Metformin—polycystic ovary syndrome	0.0226	0.0229	CcSEcCtD
Dolasetron—Palpitations—Metformin—polycystic ovary syndrome	0.0223	0.0225	CcSEcCtD
Dolasetron—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0221	0.0224	CcSEcCtD
Dolasetron—Hypertension—Metformin—polycystic ovary syndrome	0.0217	0.022	CcSEcCtD
Dolasetron—Chest pain—Metformin—polycystic ovary syndrome	0.0214	0.0217	CcSEcCtD
Dolasetron—Myalgia—Metformin—polycystic ovary syndrome	0.0214	0.0217	CcSEcCtD
Dolasetron—Discomfort—Metformin—polycystic ovary syndrome	0.0212	0.0215	CcSEcCtD
Dolasetron—Oedema—Metformin—polycystic ovary syndrome	0.0206	0.0208	CcSEcCtD
Dolasetron—Shock—Metformin—polycystic ovary syndrome	0.0202	0.0205	CcSEcCtD
Dolasetron—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.0201	0.0204	CcSEcCtD
Dolasetron—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0199	0.0201	CcSEcCtD
Dolasetron—Anorexia—Metformin—polycystic ovary syndrome	0.0196	0.0198	CcSEcCtD
Dolasetron—Hypotension—Metformin—polycystic ovary syndrome	0.0192	0.0194	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0187	0.019	CcSEcCtD
Dolasetron—Paraesthesia—Metformin—polycystic ovary syndrome	0.0185	0.0187	CcSEcCtD
Dolasetron—Dyspnoea—Metformin—polycystic ovary syndrome	0.0183	0.0186	CcSEcCtD
Dolasetron—Somnolence—Metformin—polycystic ovary syndrome	0.0183	0.0185	CcSEcCtD
Dolasetron—Dyspepsia—Metformin—polycystic ovary syndrome	0.0181	0.0183	CcSEcCtD
Dolasetron—Decreased appetite—Metformin—polycystic ovary syndrome	0.0179	0.0181	CcSEcCtD
Dolasetron—Fatigue—Metformin—polycystic ovary syndrome	0.0177	0.0179	CcSEcCtD
Dolasetron—Constipation—Metformin—polycystic ovary syndrome	0.0176	0.0178	CcSEcCtD
Dolasetron—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0169	0.0172	CcSEcCtD
Dolasetron—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0168	0.017	CcSEcCtD
Dolasetron—Urticaria—Metformin—polycystic ovary syndrome	0.0163	0.0165	CcSEcCtD
Dolasetron—Abdominal pain—Metformin—polycystic ovary syndrome	0.0163	0.0165	CcSEcCtD
Dolasetron—Asthenia—Metformin—polycystic ovary syndrome	0.0148	0.0149	CcSEcCtD
Dolasetron—Pruritus—Metformin—polycystic ovary syndrome	0.0145	0.0147	CcSEcCtD
Dolasetron—Diarrhoea—Metformin—polycystic ovary syndrome	0.0141	0.0142	CcSEcCtD
Dolasetron—Dizziness—Metformin—polycystic ovary syndrome	0.0136	0.0138	CcSEcCtD
Dolasetron—Rash—Metformin—polycystic ovary syndrome	0.013	0.0131	CcSEcCtD
Dolasetron—Dermatitis—Metformin—polycystic ovary syndrome	0.013	0.0131	CcSEcCtD
Dolasetron—Headache—Metformin—polycystic ovary syndrome	0.0129	0.013	CcSEcCtD
Dolasetron—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.000616	0.0504	CbGpPWpGaD
Dolasetron—HTR3A—Ion channel transport—TRPV6—polycystic ovary syndrome	0.000463	0.0379	CbGpPWpGaD
Dolasetron—HTR3A—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.000419	0.0342	CbGpPWpGaD
Dolasetron—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000343	0.028	CbGpPWpGaD
Dolasetron—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000276	0.0226	CbGpPWpGaD
Dolasetron—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000264	0.0216	CbGpPWpGaD
Dolasetron—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000251	0.0205	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000248	0.0203	CbGpPWpGaD
Dolasetron—CYP2D6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000245	0.02	CbGpPWpGaD
Dolasetron—CYP2C9—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000243	0.0198	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000226	0.0185	CbGpPWpGaD
Dolasetron—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00019	0.0155	CbGpPWpGaD
Dolasetron—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000173	0.0142	CbGpPWpGaD
Dolasetron—CYP2C9—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000173	0.0142	CbGpPWpGaD
Dolasetron—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000166	0.0135	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000161	0.0132	CbGpPWpGaD
Dolasetron—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00016	0.0131	CbGpPWpGaD
Dolasetron—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00016	0.0131	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000157	0.0129	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000146	0.0119	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00014	0.0115	CbGpPWpGaD
Dolasetron—CYP2D6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000134	0.0109	CbGpPWpGaD
Dolasetron—CYP2C9—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000133	0.0108	CbGpPWpGaD
Dolasetron—CYP2D6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000129	0.0105	CbGpPWpGaD
Dolasetron—CYP2C9—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000127	0.0104	CbGpPWpGaD
Dolasetron—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000114	0.00934	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000113	0.00926	CbGpPWpGaD
Dolasetron—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000105	0.00855	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000101	0.00829	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	9.93e-05	0.00812	CbGpPWpGaD
Dolasetron—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	9.51e-05	0.00778	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	9.36e-05	0.00766	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	9.28e-05	0.00759	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	9.24e-05	0.00755	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	9.16e-05	0.00749	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	8.77e-05	0.00717	CbGpPWpGaD
Dolasetron—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	8.74e-05	0.00715	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	8.7e-05	0.00712	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	8.69e-05	0.00711	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	8.63e-05	0.00706	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	8.59e-05	0.00702	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	8.51e-05	0.00696	CbGpPWpGaD
Dolasetron—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	8.41e-05	0.00687	CbGpPWpGaD
Dolasetron—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	8.08e-05	0.00661	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	7.59e-05	0.00621	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	7.52e-05	0.00615	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	7.06e-05	0.00577	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	6.99e-05	0.00572	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	6.89e-05	0.00563	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	6.83e-05	0.00558	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	6.8e-05	0.00556	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	6.74e-05	0.00551	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	6.55e-05	0.00536	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	6.37e-05	0.00521	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	6.12e-05	0.00501	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.08e-05	0.00497	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	6.04e-05	0.00494	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	5.73e-05	0.00469	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	5.69e-05	0.00465	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.66e-05	0.00462	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	5.62e-05	0.00459	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	5.58e-05	0.00457	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	5.57e-05	0.00455	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	5.55e-05	0.00454	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	5.54e-05	0.00453	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	5.5e-05	0.0045	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	5.48e-05	0.00448	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	5.44e-05	0.00445	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	5.43e-05	0.00444	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.17e-05	0.00423	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	4.96e-05	0.00406	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	4.88e-05	0.00399	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	4.84e-05	0.00395	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	4.61e-05	0.00377	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	4.55e-05	0.00372	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	4.51e-05	0.00369	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	4.5e-05	0.00368	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	4.5e-05	0.00368	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	4.49e-05	0.00367	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	4.49e-05	0.00367	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	4.46e-05	0.00365	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	4.45e-05	0.00364	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	4.44e-05	0.00363	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.34e-05	0.00355	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	4.32e-05	0.00353	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	4.28e-05	0.0035	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	4.14e-05	0.00338	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	4.1e-05	0.00336	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	4.03e-05	0.0033	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	4e-05	0.00327	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.98e-05	0.00325	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.94e-05	0.00322	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.76e-05	0.00308	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	3.75e-05	0.00307	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	3.75e-05	0.00306	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	3.72e-05	0.00304	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	3.72e-05	0.00304	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	3.7e-05	0.00302	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	3.66e-05	0.003	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	3.65e-05	0.00299	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	3.63e-05	0.00297	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	3.58e-05	0.00293	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	3.38e-05	0.00277	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	3.38e-05	0.00277	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	3.36e-05	0.00274	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	3.33e-05	0.00272	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	3.19e-05	0.00261	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	2.98e-05	0.00243	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.97e-05	0.00243	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	2.94e-05	0.00241	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.94e-05	0.0024	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	2.93e-05	0.0024	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.93e-05	0.00239	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.9e-05	0.00237	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	2.84e-05	0.00232	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	2.71e-05	0.00221	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	2.69e-05	0.0022	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	2.64e-05	0.00216	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	2.6e-05	0.00213	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	2.56e-05	0.0021	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	2.45e-05	0.00201	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	2.45e-05	0.002	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.42e-05	0.00198	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.39e-05	0.00195	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.37e-05	0.00194	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.36e-05	0.00193	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.34e-05	0.00191	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.19e-05	0.00179	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	2.18e-05	0.00178	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	2.1e-05	0.00172	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	2.08e-05	0.0017	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.99e-05	0.00163	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.94e-05	0.00159	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	1.94e-05	0.00159	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	1.92e-05	0.00157	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	1.92e-05	0.00157	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	1.91e-05	0.00156	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	1.91e-05	0.00156	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	1.91e-05	0.00156	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.88e-05	0.00154	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	1.79e-05	0.00146	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	1.78e-05	0.00146	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	1.77e-05	0.00145	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	1.77e-05	0.00145	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.73e-05	0.00142	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.62e-05	0.00132	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.56e-05	0.00128	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.54e-05	0.00126	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.53e-05	0.00125	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	1.52e-05	0.00124	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	1.52e-05	0.00124	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	1.51e-05	0.00123	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	1.51e-05	0.00123	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.45e-05	0.00119	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.43e-05	0.00117	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.37e-05	0.00112	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	1.27e-05	0.00104	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	1.26e-05	0.00103	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.26e-05	0.00103	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.26e-05	0.00103	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	1.21e-05	0.000988	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	1.2e-05	0.000979	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.17e-05	0.000956	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.17e-05	0.000953	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	1.15e-05	0.000942	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	1.14e-05	0.000934	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.13e-05	0.000923	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.03e-05	0.00084	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	1.02e-05	0.000833	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	9.94e-06	0.000813	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	9.94e-06	0.000813	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	9.8e-06	0.000801	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	9.71e-06	0.000794	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.6e-06	0.000785	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.1e-06	0.000744	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	8.93e-06	0.000731	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	8.86e-06	0.000724	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	8.73e-06	0.000714	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	8.66e-06	0.000708	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	8.46e-06	0.000692	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	8.38e-06	0.000686	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	8.33e-06	0.000681	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	7.9e-06	0.000646	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	7.78e-06	0.000636	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	7.72e-06	0.000631	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	7.54e-06	0.000616	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	7.53e-06	0.000616	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	7.47e-06	0.000611	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	7.27e-06	0.000594	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	7.2e-06	0.000589	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	6.98e-06	0.000571	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	6.92e-06	0.000566	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	6.89e-06	0.000564	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.88e-06	0.000563	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	6.83e-06	0.000559	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.79e-06	0.000555	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	6.71e-06	0.000549	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	6.51e-06	0.000532	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	6.45e-06	0.000528	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	6.41e-06	0.000524	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	6.41e-06	0.000524	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	6.35e-06	0.00052	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.84e-06	0.000478	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.71e-06	0.000467	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—TH—polycystic ovary syndrome	5.55e-06	0.000453	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.53e-06	0.000452	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—TH—polycystic ovary syndrome	5.5e-06	0.00045	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	5.39e-06	0.000441	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	5.35e-06	0.000437	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.09e-06	0.000416	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	5.07e-06	0.000415	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	5.03e-06	0.000411	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.93e-06	0.000403	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.75e-06	0.000388	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.56e-06	0.000373	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	4.53e-06	0.00037	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.51e-06	0.000369	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.49e-06	0.000367	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	4.31e-06	0.000353	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	4.28e-06	0.00035	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.26e-06	0.000348	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.19e-06	0.000343	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	4.09e-06	0.000334	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	4.05e-06	0.000331	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	3.81e-06	0.000312	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.78e-06	0.000309	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.63e-06	0.000296	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.53e-06	0.000288	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.32e-06	0.000271	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.09e-06	0.000253	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	3.06e-06	0.000251	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.05e-06	0.000249	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.03e-06	0.000248	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	3.02e-06	0.000247	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—INS—polycystic ovary syndrome	3.01e-06	0.000246	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.96e-06	0.000242	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.82e-06	0.000231	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.67e-06	0.000219	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.49e-06	0.000204	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.02e-06	0.000165	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.99e-06	0.000163	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.98e-06	0.000162	CbGpPWpGaD
